Rob Surgical Systems

What Rob Surgical Systems does

Rob Surgical Systems, SL is a Barcelona-based medical robotics company founded in 2011 as a spin-off from the Universitat Politècnica de Catalunya (UPC) and the Institut de Bioenginyeria de Catalunya (IBEC). The company develops the Bitrack System, an open robotic surgical platform consisting of a portable column with four mobile arms that provide submillimeter precision control and multi-quadrant surgical access via a proprietary Dynamic Fulcrum Point architecture. The platform supports hybrid surgery, allowing surgeons to combine manual minimally invasive surgery (MIS) and robotic minimally invasive robotic surgery (MIRS) within a single procedure through open ports that accommodate both robotic and standard laparoscopic instruments simultaneously, and ships with 8mm single-use instruments offering 7 degrees of freedom at the tip.

The company targets hospitals of all sizes — including regional and mid-tier facilities that cannot afford incumbent da Vinci-class systems — through a pay-per-use commercial model under which Rob Surgical retains ownership of the robot, manages storage, maintenance, and transportation, and charges hospitals per procedure. The company claims the model reduces per-procedure cost by more than half versus traditional surgical robots and that the portable, door- and elevator-compatible design enables one robot to serve multiple hospitals in a single day. Rob Surgical also sells or bundles a 3D vision system and a surgical Data System that captures procedure-level data for clinical and commercial KPIs.

As of the input data, Rob Surgical has completed two series of urological clinical surgeries (partial and radical nephrectomies) at Hospital Clínic of Barcelona under AEMPS authorization, with no adverse events at 30-day follow-up. The company is currently pending CE Mark approval and is not yet commercially available, employs approximately 40 professionals across five nationalities, and has been building out commercial leadership (Commercial Director in November 2024, General Manager in July 2025) ahead of market entry.

Name

Rob Surgical Systems

Legal name

Rob Surgical Systems, SL

Website

http://robsurgical.com/

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Rob Surgical Systems is a Barcelona-based medical robotics company developing the Bitrack System, an open four-arm robotic platform for minimally invasive surgery that targets hospitals of all sizes via a pay-per-use model. Founded in 2011 as a UPC/IBEC spin-off, the company is currently pending CE Mark approval.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Healthcare & Assistive Robotics (HDAAAIAC), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Surgical robotics
• Minimally invasive surgery
• Robotic surgery platform
• Medical robotics systems
• Laparoscopic surgical robot

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pay-Per-Use (PPU) Surgical Robot Services: The primary revenue model is a usage-based approach where hospitals pay for each surgical procedure performed using the Bitrack System. This eliminates the need for large capital investment by hospitals, reduces costs by more than half compared to traditional surgical robots, and allows Rob Surgical to store, maintain, and manage the robot while providing services to multiple hospitals.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Rob Surgical Systems designs and manufactures the Bitrack System, an open robotic surgical platform featuring a four-arm column with a Dynamic Fulcrum Point that enables multi-quadrant access and submillimeter precision for minimally invasive surgery. The platform supports Hybrid Surgery (combining MIS and MIRS in one procedure), uses single-use instruments compatible with standard trocars, and is delivered to hospitals on a pay-per-use basis with the company managing robot logistics and maintenance.

Product overview

Rob Surgical Systems offers the Bitrack System, a single unified surgical robotics platform built around an open, portable four-arm robotic column. The platform is designed to improve the efficiency of minimally invasive surgery through three integrated layers: the robotic hardware (four arms with 7 degrees of freedom), the hybrid surgery capability (allowing seamless switching between manual MIS and robotic MIRS), and the digital ecosystem (3D vision system, single-use instruments, and a data system for surgical KPIs). The company commercializes its platform primarily through a pay-per-use model and is currently pending CE Mark approval before full European commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• Bitrack System: The surgical robot platform developed by Rob Surgical that provides high-precision, minimally invasive robotic surgery with an open platform design, hybrid surgery capability, and portable/transportable features for universalizing precision surgery.

Products and services

• Bitrack System Open robotic surgical platform featuring a four-arm column with a Dynamic Fulcrum Point, supporting Hybrid Surgery (combining MIS and MIRS), single-use 8mm instruments with 7 degrees of freedom, and an open 3D vision system; targeted at hospitals of all sizes and delivered under a pay-per-use model.

Quantifiable outcome

• Cost per operation reduced by more than half compared to traditional surgical robots
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Six partnerships are on record, tiered minor and core.

• PASS Program Partners (ABLE Human Motion, Doctomatic, Goodgut)minorStrategic or Co-development Partner · 30 July 2024Selected as one of four companies in the Program for Innovation Access to the Health System of Catalonia, developed by Servei Català de la Salut, AQuAS, and Biocat. The program aims to introduce pioneering innovations into the Catalan healthcare system.
• Hospital Clínic of BarcelonacoreStrategic or Co-development Partner · 15 June 2023Strategic clinical collaboration for validation of the Bitrack surgical robot in urology procedures. The partnership has completed two series of patient surgeries (June and November 2023) including radical nephrectomies. Led by Dr. Antonio Alcaraz with surgeons Dr. Lluís Peri and Dr. Mireia Musquera. All surgeries completed successfully with no adverse events.
• Universitat Politècnica de Catalunya (UPC)coreStrategic or Co-development PartnerFounding institution - Rob Surgical is a spin-off created by UPC. The university provided research foundation and continued academic collaboration in robotics development.
• Institut de Bioenginyeria de Catalunya (IBEC)coreStrategic or Co-development PartnerFounding institution - Rob Surgical is a spin-off created by IBEC. The institute provides bioengineering research expertise supporting the surgical robotics development.
• SpecipigminorImplementation/ SI/ Consulting PartnerContract Research Organization focused on pig models that conducted preclinical animal testing for the Bitrack System prior to human clinical trials.
• CMCiB (Comparative Medicine and Bioimage Centre) at Germans Trias i PujolminorImplementation/ SI/ Consulting PartnerResearch center that conducted preclinical testing on corpse models for the Bitrack System as part of the clinical validation process.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Intuitive Surgical: The dominant incumbent in robotic-assisted surgery with the da Vinci platform, which has thousands of installed systems globally. Rob Surgical is positioning Bitrack as a lower-cost, more accessible alternative to da Vinci, directly targeting the market Intuitive has created.
• Medtronic: Developer of the Hugo robotic-assisted surgery platform, a modular system that competes in the same minimally invasive surgery market as Bitrack. Medtronic's scale, regulatory capabilities, and existing hospital relationships pose a significant competitive threat.
• Stryker (Mako): Owner of the Mako robotic surgery platform, dominant in orthopedic procedures. While ortho-focused, Stryker represents the broader competitive landscape of incumbent medical device companies deploying capital and sales force to defend robotic surgery market share.

Direct peers

• Asensus Surgical: Developer of the Senhance surgical robot, a competitor in the minimally invasive robotic surgery market. Both target hospitals seeking cost-effective alternatives to da Vinci and pursue similar surgeon-friendly, open-platform philosophies.
• CMR Surgical: UK-based developer of the Versius surgical robot, a modular, portable system targeting the same cost-accessible robotic surgery market as Bitrack. Both are European-headquartered, pre-IPO challengers to da Vinci with similar go-to-market strategies.
• Distalmotion: Swiss developer of the Dexter surgical robot, a portable system designed to bring robotic surgery to more hospitals at lower cost. Shares Bitrack's design philosophy of portability, modularity, and accessibility versus large incumbent systems.

Regional players

• Medicaroid: Japan-based joint venture (Kawasaki Heavy Industries and Sysmex) developing the Hinotori surgical robot. Competes in minimally invasive robotic surgery with a regional focus on Asian markets but targets the same global opportunity as Bitrack.
• Avateramedical: European developer of the avatera system, a CE-marked surgical robot focused on European market entry. Represents a directly comparable European challenger pursuing the same cost-accessible robotic surgery positioning as Rob Surgical.

Emerging players

• meerecompany: South Korea-based developer of the Revo-i surgical robot, a direct competitor in the minimally invasive robotic surgery category. Competes on similar value proposition of accessibility and cost-effectiveness versus da Vinci.
• SS Innovations: Developer of the SSi Mantra surgical robot, an emerging competitor targeting cost-effective robotic surgery in emerging markets. Shares Bitrack's positioning as a lower-cost alternative to da Vinci for underserved hospital segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rob Surgical Systems